The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 18, 2025

Filed:

Jun. 29, 2023
Applicant:

Gholam A. Peyman, Sun City, AZ (US);

Inventor:

Gholam A. Peyman, Sun City, AZ (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 31/132 (2006.01); A61K 31/155 (2006.01); A61K 31/4045 (2006.01); A61K 39/00 (2006.01); A61K 39/02 (2006.01); A61K 39/12 (2006.01); A61K 45/06 (2006.01); A61M 1/14 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 31/132 (2013.01); A61K 31/155 (2013.01); A61K 31/4045 (2013.01); A61K 39/0002 (2013.01); A61K 39/0011 (2013.01); A61K 39/02 (2013.01); A61K 39/12 (2013.01); A61K 45/06 (2013.01); A61M 1/14 (2013.01); A61K 2039/55511 (2013.01);
Abstract

A method for producing an immunogenic composition includes growing viruses, bacteria, fungi, parasites, or tumor cells on a cell culture or other appropriate medium; harvesting the viruses, bacteria, fungi, parasites, or tumor cells; killing the viruses, bacteria, fungi, parasites, or tumor cells with one or more medications that damage the RNA and/or the DNA of the viruses, bacteria, fungi, parasites, or tumor cells; separating the dead viruses, bacteria, fungi, parasites, or tumor cells; depending on the type of organism, adding antivirals, antibacterials, antifungals, antiparasitics, and/or anti-neoplastic medications at non-toxic concentrations to the dead viruses, bacteria, fungi, parasites, or tumor cells so as to form an immunogenic composition; and administering the immunogenic composition and an adjuvant to a patient in need thereof.


Find Patent Forward Citations

Loading…